{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:24:18Z","timestamp":1774311858502,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jaccas.2020.11.030","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T16:41:50Z","timestamp":1611765710000},"page":"586-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest"],"prefix":"10.1016","volume":"3","author":[{"given":"Harold","family":"Rivner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Litsa K.","family":"Lambrakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2020.11.030_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/europace\/euq382","article-title":"Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation","volume":"13","author":"Aliot","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jaccas.2020.11.030_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12012-016-9380-0","article-title":"Flecainide toxicity: a case report and systematic review of its electrocardiographic patterns and management","volume":"17","author":"Valentino","year":"2017","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jaccas.2020.11.030_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4330\/wjc.v7.i2.76","article-title":"Flecainide: current status and perspectives in arrhythmia management","volume":"7","author":"Andrikopoulos","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jaccas.2020.11.030_bib4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1540-8159.1983.tb04410.x","article-title":"Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds","volume":"6","author":"Hellestrand","year":"1983","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jaccas.2020.11.030_bib5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/europace\/eut429","article-title":"Electrophysiological and haemodynamic effects of vernakalant and flecainide in dyssynchronous canine hearts","volume":"16","author":"van Middendorp","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jaccas.2020.11.030_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/oxfordjournals.eurheartj.a062178","article-title":"Negative inotropic effect of class-I-antiarrhythmic drugs: comparison of flecainide with disopyramide and quinidine","volume":"8","author":"Hoffmeister","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccas.2020.11.030_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccas.2020.11.030_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Brandes","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccas.2020.11.030_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/clpt.1988.57","article-title":"Pharmacokinetics of flecainide acetate in patients with severe renal impairment","volume":"43","author":"Williams","year":"1988","journal-title":"Clin Pharmacol Ther"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084920314273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084920314273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:48:03Z","timestamp":1762973283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084920314273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2666084920314273"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2020.11.030","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2020.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}